NCT07014670

Brief Summary

The aim of this study was to examine the validity and reliability of the Turkish version of the Postural Habits and Awareness Scale in Fibromyalgia patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

2 months

First QC Date

June 3, 2025

Last Update Submit

September 19, 2025

Conditions

Keywords

reabilityvalidityPostural Habit and Awareness Scale

Outcome Measures

Primary Outcomes (1)

  • Postural Habit and Awareness Scale

    Developed by Turkish researchers Bayar and his colleagues, the scale has 19 items and four factors. The factors of the scale are posture habits and awareness, awareness of factors that disrupt posture, positional awareness and ergonomic awareness. Postural habits are examined with seven items and postural awareness is examined with twelve items in the scale. Scoring is 5-point Likert type, the minimum score is one for each proposition; the maximum score is five. The total score is a maximum of 95.

    7-10 days

Secondary Outcomes (5)

  • Fibromyalgia Impact Questionnaire

    2 days

  • Body Perception Scale

    2 days

  • Body Awareness Questionnaire

    2 days

  • Visual Analog Scale

    2 days

  • Short Form-12

    2 days

Interventions

Validation and Reability study

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Fibromyalgia

You may qualify if:

  • Those who have been diagnosed with Fibromyalgia according to the American Rheumatology Association criteria and have been over for at least 6 months,
  • Those who do not have a history of any psychiatric disease,
  • Those who have the ability to lie down, sit and stand without any assistance.

You may not qualify if:

  • Pregnant individuals,
  • Those who have pain complaints due to another disease (rheumatic, heart or infectious diseases),
  • Those who make changes in physical activity and lifestyle during work,
  • Those with any neurological disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bitlis Eren University

Bitlis, Merkez, 13000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

June 3, 2025

First Posted

June 11, 2025

Study Start

April 25, 2025

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

September 23, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations